Focal Shockwave
Therapy in London

Peyronie's disease involves fibrous plaques within the tunica albuginea causing penile curvature, pain and sexual dysfunction. Focal shockwave addresses the condition through calcification dissolution — mechanically disrupting plaques and stimulating tissue remodelling. Drug-free and non-surgical.

Frozen shoulder causes progressive loss of range of motion and pain. Focal shockwave reduces capsular fibrosis through inflammation modulation, stimulates neovascularisation and supports tissue remodelling — restoring movement without surgery or steroid injections.

Chronic plantar fasciitis fails to resolve because tissue enters a non-healing degenerative state. The Gollwitzer 2015 RCT (n=246) demonstrated superiority over sham at 12 weeks with maintained benefit at 12 months — confirming repeated sessions are more effective than single high-dose treatment.

Focal shockwave for lateral epicondylitis demonstrated meaningful improvement in pain and function at 6 and 12 months, with superiority over corticosteroid injection at 12-month follow-up (Spacca 2005 RCT; Buchbinder Cochrane review).

The Louwerens 2014 multi-centre RCT (n=152) demonstrated complete or partial resorption of calcium deposits in 86% of the high-energy group at 12 months — confirming energy level as a critical determinant of outcome.

Focal shockwave accelerates healing in tendinopathies and stress fractures through stem cell activation and neovascularisation. Used across elite sports medicine for Achilles tendinopathy, patellar tendinopathy and sports-related soft tissue injuries.

Focal shockwave addresses chronic pain through neuromodulation — altering peripheral nerve conduction and central pain signalling — alongside biological repair mechanisms that resolve underlying pathology. Effective for chronic tendinopathy, osteoarthritis and soft tissue conditions.

Focal shockwave therapy has an established safety profile across decades of clinical use and multiple published RCTs. Every patient undergoes thorough contraindication screening by Dr Bahl before treatment begins. Common temporary effects include mild localised discomfort or redness immediately after treatment, resolving within 24 hours. Serious adverse events are rare when treatment is delivered by a qualified medical practitioner using appropriate protocols.

The number of sessions depends on your condition, severity and individual response. Most patients require between 3 and 6 sessions. Dr Bahl selects the correct protocol at your initial consultation and monitors your response after each session, adapting treatment based on clinical progress rather than applying a fixed number regardless of outcome.

Most patients describe the sensation as tolerable — a repetitive pressure or mild discomfort at the treatment site rather than pain. Intensity is adjustable and Dr Bahl will adapt parameters to your comfort level throughout. No anaesthetic is required. There is no recovery time after treatment.

Many patients notice initial improvement within 2–3 sessions. Results continue to consolidate over 4–12 weeks post-treatment as the biological repair mechanisms activated by shockwave therapy complete their work. The full treatment response is typically assessed 4–6 weeks after completing the course.

No. Dr Bahl's clinical expertise and time are reflected in our pricing. ED Treatment and Peyronie's Disease start from £250 per session. All other treatments start from £180 per session. Every consultation is a full clinical assessment — not a sales meeting.